
1. General Information
BDRON 500 mg Tablet contains abiraterone acetate, a hormonal anticancer medicine belonging to the class of CYP17 inhibitors. It is primarily used as part of treatment for advanced or metastatic prostate cancer.
Abiraterone works by reducing the production of androgens (male hormones). Since prostate cancer cells can depend on androgen signaling for growth, reducing androgen production can help slow disease progression.
BDRON 500 mg is a prescription medicine and should be used only under the supervision of an oncologist or qualified healthcare professional.
2. Product Information
- Product: BDRON 500 mg Tablet
- Active ingredient: Abiraterone acetate 500 mg
- Dosage form: Oral tablet
- Therapeutic category: Anticancer / hormonal therapy
- Drug class: CYP17 inhibitor
- Primary therapeutic area: Prostate cancer
- Administration: Oral
- Prescription status: Prescription medicine
Abiraterone acetate products are available in different strengths and formulations, and their administration instructions can differ. Therefore, patients should follow the specific product's prescribing information rather than assuming that instructions for another abiraterone product are identical.
3. Uses of BDRON 500 mg Tablet
BDRON 500 mg (abiraterone acetate) may be prescribed as part of treatment for:
- Metastatic castration-resistant prostate cancer (mCRPC)
- Metastatic high-risk castration-sensitive prostate cancer (mCSPC)
The exact treatment combination depends on the patient's disease status and the oncologist's treatment plan. Abiraterone is generally administered in combination with a corticosteroid and appropriate androgen-deprivation therapy.
4. Benefits of BDRON 500 mg Tablet
When appropriately prescribed, abiraterone acetate may provide the following therapeutic benefits:
- Helps reduce androgen production in the body.
- Helps suppress hormonal stimulation of prostate cancer cells.
- Can be incorporated into treatment plans for advanced or metastatic prostate cancer.
- Provides a targeted hormonal-treatment approach rather than conventional cytotoxic chemotherapy.
- May help delay disease progression when used in appropriate patients as part of an oncologist-directed treatment regimen.
The benefits depend on the individual's cancer type, stage, previous treatment and overall health.
5. Side Effects of BDRON 500 mg Tablet
Like other prescription anticancer medicines, abiraterone acetate can cause side effects. Important adverse effects are associated partly with mineralocorticoid excess and may include:
- High blood pressure
- Low potassium levels
- Fluid retention or swelling
- Liver-function abnormalities
- Fatigue
- Joint or muscle discomfort
- Headache
- Gastrointestinal symptoms
More serious complications can occur, including significant liver toxicity, cardiovascular complications and adrenal insufficiency. Regular medical monitoring is therefore important.
6. Common Side Effects
Potentially common or clinically observed adverse effects can include:
- Fatigue
- Nausea
- Joint swelling or discomfort
- Muscle discomfort
- Hot flushes
- Diarrhea
- Increased blood pressure
- Peripheral edema
- Low potassium
- Abnormal liver-function tests
Patients should inform their doctor about persistent or troublesome symptoms rather than stopping treatment independently.
7. How to Use BDRON 500 mg Tablet
BDRON 500 mg should be taken exactly according to the oncologist's prescription.
Important points include:
- Swallow the tablet as directed.
- Do not change the prescribed dose yourself.
- Abiraterone products have important food-related administration requirements; the exact instructions should be followed according to the specific product label.
- It is generally used together with a prescribed corticosteroid.
- Do not discontinue corticosteroid therapy without medical advice.
- If a dose is missed, follow the product's prescribing instructions or contact the treating physician/pharmacist.
The commonly approved abiraterone acetate regimen for standard 250/500 mg-tablet products is often based on a 1,000 mg total daily dose, but dosing can vary according to the formulation, indication, liver function and treatment regimen. Therefore, the patient should not calculate the dose independently.
8. How BDRON 500 mg Works
Abiraterone acetate is converted in the body to abiraterone, which inhibits the CYP17 enzyme pathway.
This pathway is involved in androgen production in the testes, adrenal glands and prostate tumor tissue. By inhibiting CYP17, abiraterone substantially reduces androgen production.
Lower androgen levels can reduce hormonal stimulation of prostate cancer cells and help control disease progression. Because CYP17 inhibition can also increase mineralocorticoid-related effects, corticosteroid treatment and monitoring are commonly incorporated into therapy.
9. Safety Advice for BDRON 500 mg
BDRON 500 mg should only be used under appropriate medical supervision.
Important precautions
- Liver: Liver function should be monitored because abiraterone can cause hepatotoxicity.
- Blood pressure: Blood pressure should be checked regularly.
- Potassium: Potassium levels require monitoring because treatment can cause hypokalemia.
- Fluid retention: Report swelling, rapid weight gain or breathing difficulties.
- Heart conditions: Patients with cardiovascular disease should discuss their medical history with their doctor.
- Adrenal function: Adrenal insufficiency can occur, particularly in situations of physiological stress or interruption of corticosteroid treatment.
- Pregnancy: Abiraterone can cause fetal harm. Appropriate precautions are required around pregnancy and exposure to the medicine.
- Drug interactions: Tell the doctor about all prescription medicines, OTC medicines, vitamins and supplements.
- Do not self-medicate: This is an oncology prescription medicine and should not be started, stopped or dose-adjusted without specialist advice.
The FDA-approved information specifically warns about hypokalemia, fluid retention, cardiovascular adverse reactions, adrenal insufficiency and hepatotoxicity.
10. Frequently Asked Questions
Q1. What is BDRON 500 mg Tablet?
BDRON 500 mg Tablet is an abiraterone acetate-containing prescription medicine used as part of treatment for certain advanced or metastatic prostate cancers.
Q2. What is the active ingredient in BDRON 500 mg?
The active ingredient is abiraterone acetate 500 mg, assuming the composition stated on the product packaging is correct.
Q3. Is BDRON 500 mg a chemotherapy medicine?
It is better described as a hormonal/androgen-deprivation targeted therapy, rather than conventional cytotoxic chemotherapy.
Q4. What cancer is abiraterone used for?
It is used in specific treatment settings for advanced or metastatic prostate cancer, including metastatic castration-resistant and certain metastatic castration-sensitive disease.
Q5. Can BDRON 500 mg be taken without a prescription?
No. Abiraterone is a prescription anticancer medicine and should be used under specialist supervision.
Q6. Does abiraterone need to be taken with another medicine?
It is generally prescribed with a corticosteroid such as prednisone or methylprednisolone, depending on the treatment regimen. Appropriate androgen-deprivation therapy may also be required.
Q7. Does BDRON 500 mg cure prostate cancer?
It should not be described as a guaranteed cure. Its purpose is to help control androgen-dependent prostate cancer and manage disease progression in appropriate patients.
Q8. Does BDRON 500 mg have serious side effects?
Yes. Important risks include liver toxicity, low potassium, fluid retention, increased blood pressure, cardiovascular complications and adrenal insufficiency. Medical monitoring is essential.
Q9. Can the dose be changed if side effects occur?
No. Dose changes should be made only by the treating physician, who may use laboratory tests and clinical findings to determine the appropriate adjustment.
Q10. Is BDRON 500 mg suitable for everyone with prostate cancer?
No. Suitability depends on the cancer's characteristics, stage, previous treatments, liver function, cardiovascular status and other clinical factors.
11. Substitute for BDRON 500 mg Tablet
A substitute should contain the same active ingredient and appropriate strength/formulation, but the correct alternative must be selected by a doctor or pharmacist.
Possible alternatives may include other abiraterone acetate products, including generic abiraterone products and branded products such as Zytiga, depending on availability and local regulatory status. Zytiga contains abiraterone acetate.
Important: Do not replace BDRON 500 mg with enzalutamide, apalutamide, darolutamide or another prostate-cancer medicine without medical advice. These are different medicines with different indications, mechanisms, interactions and safety profiles.
12. SEO & B2B Keywords
Primary Keywords
- BDRON 500 mg Tablet
- BDRON 500 mg
- BDRON 500 mg Tablet exporter
- BDRON 500 mg supplier
- BDRON 500 mg pharmaceutical exporter
- Abiraterone Acetate 500 mg Tablet
- Abiraterone 500 mg Tablet exporter
- Abiraterone Acetate supplier India
- Abiraterone prostate cancer medicine
- Abiraterone acetate pharmaceutical supplier
Long-Tail B2B Keywords
- BDRON 500 mg Tablet pharmaceutical exporter from India
- BDRON 500 mg Tablet supplier from Nagpur India
- Abiraterone Acetate 500 mg Tablet exporter from India
- Abiraterone 500 mg medicine supplier India
- BDRON 500 mg wholesale pharmaceutical supplier
- Abiraterone Acetate 500 mg B2B medicine supplier
- BDRON 500 mg Tablet international pharmaceutical supplier
- Abiraterone prostate cancer medicine exporter India
- Generic abiraterone acetate 500 mg pharmaceutical supplier
- BDRON 500 mg oncology medicine supplier India
- BDRON 500 mg Tablet export supplier Nagpur
- Abiraterone Acetate 500 mg oncology medicine exporter
Country-Focused Keywords
- BDRON 500 mg Tablet exporter to USA
- BDRON 500 mg Tablet supplier to UK
- BDRON 500 mg Tablet exporter to Australia
- BDRON 500 mg Tablet supplier to Singapore
- BDRON 500 mg Tablet exporter to Canada
- BDRON 500 mg Tablet supplier to South Korea
- BDRON 500 mg Tablet exporter to UAE
- Abiraterone Acetate 500 mg exporter from India to USA
- Abiraterone Acetate 500 mg supplier for UK
- Abiraterone 500 mg pharmaceutical exporter Australia
- Abiraterone 500 mg medicine supplier Canada
- Abiraterone oncology medicine exporter UAE
Phoenix Exim SEO Phrases
- Phoenix Exim BDRON 500 mg Tablet exporter
- Phoenix Exim Abiraterone Acetate supplier India
- BDRON 500 mg Tablet exporter from Nagpur India
- Phoenix Exim oncology medicine exporter
- Trusted pharmaceutical exporter from Nagpur India
- BDRON 500 mg international medicine supplier
- Abiraterone Acetate 500 mg export supplier from India
- Phoenix Exim prostate cancer medicine supplier
Keywords







